SCHEMBL19909480

SCHEMBL19909480

Cc1nc(C)nc(-c2ccc3c(c2)c2ccccc2n3-c2cc(C#N)c(-c3ccncc3)cc2-n2c3ccccc3c3cc(-c4nc(C)nc(C)n4)ccc32)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 2/20 0.35
XDH P47989 1/20 0.35
PTGER4 P35408 1/20 0.35
CYP2C19 P33261 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
PDE5A O76074 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
PTGS1 P23219 1/20 0.34
PDE4A P27815 1/20 0.34
BLM P54132 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909490 0.95 PDE3B (0.38) SQORXDHCYP2C19HPGDKDM4E
SCHEMBL19909160 0.94 SQOR (0.35) SQORXDHPTGER4CYP2C19HPGD
SCHEMBL19919707 0.94 SQOR (0.35) SQORXDHCYP2C19HPGDKDM4E
SCHEMBL19909491 0.90 SQOR (0.38) SQORXDHCYP2C19HPGDLMNA
SCHEMBL19909162 0.89 PDE3B (0.37) SQORXDHCYP2C19HPGDKDM4E
SCHEMBL19919708 0.88 PDE3B (0.38) SQORXDHCYP2C19HPGDKDM4E
SCHEMBL22760946 0.88 PTGER4 (0.38) PTGER4CYP2C19KDM4ELMNATSHR
SCHEMBL19909163 0.88 SQOR (0.35) SQORXDHCYP2C19HPGDKDM4E
SCHEMBL19919759 0.88 PIK3CA (0.37) SQORXDHPTGER4CYP2C19HPGD
SCHEMBL21108424 0.87 L3MBTL1 (0.40) XDHPTGER4CYP2C19LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 SQOR 1580/4885XDH 483/4885PTGER4 1123/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 SQOR 225/4885XDH 40/4885PTGER4 1386/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 SQOR 1580/4885XDH 483/4885PTGER4 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.